Myocardial Infarction Unknown Status Phase 4 Trials for Prasugrel (DB06209)

Also known as: Suspected myocardial infarction (MI) / Myocardial Infarct / MI / Myocardial Infarctions / Heart Attacks / Cardiac Infarct / Heart Attack / Myocardial Infarction (MI) / Cardiovascular Stroke / Stroke, Cardiovascular / Myocardial infarction (disorder) / Acute myocardial infarction / Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction / Attack heart (NOS) / Infarct myocardial / Right ventricular infarction / Attack coronary / Infarction of heart / Cardiac infarction, NOS / Attack - heart / Myocardial infarction, NOS / MI - myocardial infarction / Cardiac infarction / Heart attack, NOS / Infarction of heart, NOS / Myocardial infarction (& [acute]) or coronary thrombosis / Coronary artery thrombosis / Coronary artery thrombosis (disorder) / Thrombosis coronary / Coronary thrombosis / Occlusive coronary artery thrombus / Thrombosis - coronary / CT - Coronary thrombosis / (Myocardial infarction (& [acute] or [silent] or [cardiac rupture following])) or (coronary thrombosis)

IndicationStatusPhase
DBCOND0027900 (Myocardial Infarction)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02032303
Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor .Basic Science
NCT02422888
Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by TicagrelorTreatment
NCT01823185
Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet TherapyTreatment
NCT00976092
Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial InfarctionTreatment